Headlines Expert Newsletters Covid-19 Specialties Trending Feeds Videos

Myelodysplastic syndrome refers to a group of blood disorders characterised by clonal expansion of mutated blood cells, which can progress into secondary acute myeloid...

  • 1618569501498572802 Profile photo of Madelyn

    "Given that the patient sample size was small, the results ... especially those suggesting that the treatment can overcome the adverse prognosis of RUNX1 and TP53 mutations, will need to be validated in large sample studies." Comment by Xi Zhang. https://t.co/YN6tFecxIk - view on twitter

Our results suggest that G-CSF, decitabine, and busulfan–cyclophosphamide conditioning is a better choice than busulfan–cyclophosphamide conditioning for patients with myelodysplastic syndrome-RAEB or secondary acute...

Assisted reproductive technologies (ART) are not yet systematically available to people with sickle cell disease or their parents. Fertility care for these groups requires...